Angiotensin-converting enzyme inhibitors in coronary artery disease and preserved left ventricular systolic function

We performed a systematic literature review and meta-analysis to evaluate the efficay of angiotensin-converting enzyme inhibitors in patients with coronary artery disease and normal systolic left ventricular function. Angiotensin-converting enzyme inhibitor use was associated with modest benefits, which included a reduction in cardiovascular mortality, nonfatal larizatton rates.